CytomX Therapeutics
CTMX
CTMX
102 hedge funds and large institutions have $438M invested in CytomX Therapeutics in 2025 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 29 increasing their positions, 25 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
16% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 25
82.04% less ownership
Funds ownership: 165.35% → 83.31% (-82%)
Holders
102
Holding in Top 10
–
Calls
$6.83M
Puts
$1.02M
Top Buyers
| 1 | +$19.6M | |
| 2 | +$10.8M | |
| 3 | +$8.57M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$5.47M |
| 5 |
VA
VR Adviser
New York
|
+$5.08M |
Top Sellers
| 1 | -$13.1M | |
| 2 | -$12.8M | |
| 3 | -$9.42M | |
| 4 |
VC
Vivo Capital
Palo Alto,
California
|
-$9.2M |
| 5 |
FFM
Fairmount Funds Management
West Conshohocken,
Pennsylvania
|
-$8.85M |
